1. Home
  2. RVSB vs ADVB Comparison

RVSB vs ADVB Comparison

Compare RVSB & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.10

Market Cap

108.9M

Sector

Finance

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

N/A

Current Price

$4.27

Market Cap

109.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVSB
ADVB
Founded
1923
2014
Country
United States
United States
Employees
N/A
31
Industry
Savings Institutions
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.9M
109.2M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
RVSB
ADVB
Price
$5.10
$4.27
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
38.3K
174.9K
Earning Date
04-28-2026
02-13-2026
Dividend Yield
1.58%
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
N/A
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
$9.82
N/A
P/E Ratio
$28.17
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$4.74
$0.19
52 Week High
$6.59
$5.82

Technical Indicators

Market Signals
Indicator
RVSB
ADVB
Relative Strength Index (RSI) 36.24 57.88
Support Level $5.03 $0.36
Resistance Level $5.19 $5.75
Average True Range (ATR) 0.13 0.48
MACD -0.03 -0.20
Stochastic Oscillator 18.00 13.02

Price Performance

Historical Comparison
RVSB
ADVB

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: